347 results on '"Sprecher, Dennis L."'
Search Results
2. Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia
3. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia
4. Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis
5. Evaluation of GSK2789917-induced TRPV4 inhibition in animal models of fluid induced lung injury
6. The Burden of Congestion in Patients Hospitalized With Acute Decompensated Heart Failure
7. Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects
8. Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial
9. TRPV4 Specific Inhibition Ameliorates Fluid-Induced Lung Injury
10. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia
11. Emerging Cardiovascular Risk Factors That Account for a Significant Portion of Attributable Mortality Risk in Chronic Kidney Disease
12. Lipids, Lipoproteins, and Peroxisome Proliferator Activated Receptor–δ
13. Sensitivity and specificity of pediatric lipid determinations for adult lipid status: findings from the Princeton Lipid Research Clinics Prevalence Program follow-up study
14. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events
15. Identification of a Human Whole Blood–Based Endothelial Cell Impedance Assay for Assessing Clinical Transient Receptor Potential Vanilloid 4 Target Engagement Ex Vivo
16. Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers
17. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy
18. Targeting triglycerides as prognostic indicators and determining lowest values for patient benefit
19. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: A retrospective chart review involving up to 8 years of follow-up
20. Skin cholesterol adds to Framingham risk assessment
21. Fibrinogen: associations with cardiovascular events in an outpatient clinic
22. Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity
23. Targeting pulmonary capillary permeability to reduce lung congestion in heart failure: a randomized, controlled pilot trial
24. Elevated skin tissue cholesterol levels and myocardial infarction
25. The Study Of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): Design and rationale
26. Sex hormones and the changes in adolescent male lipids: Longitudinal studies in a biracial cohort
27. Triglyceride and high-density lipoprotein cholesterol: predicting disorders in parents from their children
28. Effect of premature myocardial infarction in men on the eating habits of spouses and offspring
29. Serum Homocysteine levels and mortality in outpatients with or without Coronary artery disease: An observational study
30. Routine statin treatment after acute coronary syndromes?
31. Primary hyperlipidemia in a pediatric population: classification and effect of dietary treatment
32. Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice
33. Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
34. Triglycerides and HDL-cholesterol in pediatric patients
35. Preoperative Triglycerides Predict Post-Coronary Artery Bypass Graft Survival in Diabetic Patients: A sex analysis
36. Sex and Race Differences in Cardiovascular Disease Risk Factor Changes in Schoolchildren, 1975-1990: The Princeton School Study
37. Overweight, fat patterning, and cardiovascular disease risk factors in black and white boys
38. Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study
39. A Randomized, Placebo‐Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High‐Density Lipoprotein Cholesterol in Subjects With Dyslipidemia
40. Sex hormones and lipoproteins in adolescent male offspring of parents with premature coronary heart disease and a control group
41. Lipoprotein and Apolipoprotein Differences in Black and White Girls: The National Heart, Lung, and Blood Institute Growth and Health Study
42. Rational approach to pharmacologic reduction of cholesterol levels in children
43. Hyperlipidemia and Pancreatitis during Pregnancy in Two Sisters with a Mutation in the Lipoprotein Lipase Gene
44. Definition and application of the discretionary screening indicators according to the national cholesterol education program for children and adolescents
45. Low-Dose Combined Therapy with Fluvastatin and Cholestyramine in Hyperlipidemic Patients
46. Efficacy of Psyllium in Reducing Serum Cholesterol Levels in Hypercholesterolemic Patients on High- or Low-Fat Diets
47. The psychological functioning of children with hypercholesterolemia and their families: a preliminary investigation
48. Perspectives on cholesterol screening programs for children
49. Estradiol and testosterone effects on lipids in black and white boys aged 10 to 15 years
50. Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.